PUMA BIOTECHNOLOGY, INC. Financials
moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboardSee who Puma is hiring next, click here to view […]
PBYI
Puma Biotechnology to Present at Cowen Health Care Conference
[Business Wire] – Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 10:00 a.m. moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboardSee who Puma is hiring next, click here […]
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success
moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboardSee who Puma is hiring next, click here to view […]
Facebook Values WhatsApp Like Miracle Drug
[Bloomberg] – Facebook Inc. (FB)’s $19 billion purchase of WhatsApp Inc. is valuing the text-messaging service at a multiple investors currently only bestow on companies developing life-saving drugs. Based on a goal of reaching 1 billion WhatsApp subscri moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboardSee who Puma is hiring next, […]
Puma Biotechnology Closes $138 Million Public Offering of Common Stock
[Business Wire] – Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced the closing of an underwritten public offering of 1,126,530 shares of its common stock at a price to the public of $122.50 per share. moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboardSee who Puma is hiring next, click […]
Puma Biotechnology Announces Underwriters’ Full Exercise of Option to Purchase Additional Shares
[Business Wire] – Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced that the underwriters for its public offering of 979,592 shares of its common stock at $122.50 per share have elected to exercise in full their option t moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboardSee who Puma is […]
8:34 am Puma Biotech. prices public offering of 979,592 shares of its common stock at $122.50 per share
moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboardSee who Puma is hiring next, click here to view […]
Puma Biotechnology Prices Public Offering of Common Stock
[Business Wire] – Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced the pricing of an underwritten public offering of 979,592 shares of its common stock at $122.50 per share. moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboardSee who Puma is hiring next, click here to view […]
Puma Biotechnology Reports Fourth Quarter and Full Year 2012 Financial Results
[at noodls] – During 2012, Puma made significant progress with the clinical development of our drug candidate PB272 in HER2-positive metastatic breast cancer, HER2-positive neoadjuvant breast cancer, HER2-mutated … moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboardSee who Puma is hiring next, click here to view […]
PropThink: Puma’s Quarterly Reveals Catalysts Around the Corner
[ACN Newswire] – By Jake KingPuma Biotechnology (NYSE:PBYI) made waves last month when it uplisted to the NYSE and initiated a substantial capital raise, increasing cash and equivalents to approximately $162 million, and … moreView todays social media effects on PBYIView the latest stocks trending across Twitter. Click to view dashboard […]
